InvestorsObserver
×
News Home

Is Arcutis Biotherapeutics Inc (ARQT) Stock a Bad Value Thursday?

Thursday, November 30, 2023 01:35 PM | InvestorsObserver Analysts

Mentioned in this article

Is Arcutis Biotherapeutics Inc (ARQT) Stock a Bad Value Thursday?

A rating of 29 puts Arcutis Biotherapeutics Inc (ARQT) near the top of the Healthcare sector according to InvestorsObserver. Arcutis Biotherapeutics Inc's score of 29 means that it ranks higher than 29% of stocks in the sector. In addition, its overall score of 4 ranks it higher than 4% of all stocks.

Overall Score - 4
ARQT has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on ARQT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 4 would rank higher than 4 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Arcutis Biotherapeutics Inc Stock Today?

Arcutis Biotherapeutics Inc (ARQT) stock is trading at $1.85 as of 1:34 PM on Thursday, Nov 30, a decline of -$0.05, or -2.67% from the previous closing price of $1.90. The stock has traded between $1.83 and $2.03 so far today. Volume today is light. So far 1,274,497 shares have traded compared to average volume of 3,705,744 shares. Click Here to get the full Stock Report for Arcutis Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App